Tighter Controls on Drug Precursors and Devices

Summary#

Health Canada is proposing changes to rules about chemicals and equipment that can be used to make illegal synthetic drugs. The proposal would tighten who can buy or import certain precursors and devices, add checks and reporting requirements for businesses, and give regulators more flexibility. The public can comment until March 3, 2025.

What it does#

• Amend the Precursor Control Regulations and Schedule IX of the Controlled Drugs and Substances Act to increase oversight of precursor chemicals and certain drug-making devices.
• Make reporting of suspicious transactions to Health Canada mandatory for licensed and registered companies (it is voluntary now).
• Require businesses that handle precursors to do criminal record and background checks on key personnel and take other steps to prevent diversion to illegal markets.
• Add sale restrictions for products containing ephedrine and pseudoephedrine (building on the Interim Order Concerning the Sale of Certain Natural Health Products Containing Ephedrine or Pseudoephedrine made May 17, 2024) — for example, stopping distributors from selling these products to general retail stores (only pharmacies), and considering behind-the-counter rules or purchase limits.
• Expand registration rules so that importing component parts of pill presses and encapsulators would be treated like importing the whole device.
• Let Health Canada add or remove licence or registration conditions at any time and allow partial suspension of activities on a licence or registration so the department can act faster when risks are found.

Who's affected#

• Licensed dealers and registered companies that produce, sell, import or distribute precursor chemicals.
• Importers and exporters of pill presses, encapsulators, or their component parts.
• Pharmacies, retail distributors, and consumers who buy health products that contain ephedrine or pseudoephedrine.
• Law enforcement and border agencies, which would get more reporting and tools to trace suspicious shipments.
• The general public indirectly, because the changes target the illegal drug supply. If anything is unclear about who will be regulated, the proposal itself is the source for details.

Why it matters#

• The government says the changes are meant to make it harder for organized crime to get the chemicals and equipment used to make synthetic opioids like fentanyl. That links to public safety and the effort to reduce overdose deaths.
• Some ordinary businesses will face new paperwork, employee checks, or limits on what they can sell or import. That could change how pharmacies and distributors handle certain products.
• There could be small effects on consumer access to over‑the‑counter products that contain ephedrine or pseudoephedrine if behind‑the‑counter rules or purchase limits are adopted.
• This is a proposal, not law yet. Health Canada is taking comments until March 3, 2025 (email: csd.regulatory.policy-politique.reglementaire.dsc@hc-sc.gc.ca).